Welcome to CardioRenal
Digital therapeutics for chronic cardiovascular disease
CardioRenal is a company that develops and markets digital therapeutics solutions for chronic disease management.


We want to improve chronic patient treatment at home
CardioRenal uses the most advanced technologies to develop digital therapeutic solutions allowing chronic patient at home to benefit from a personalized medicine
Our shared vision is that now is the time to help chronic patients to have a better healthcare delivery at home.
Maurice Berenger,
Co-founder, CEO of CardioRenal
Chronic kidney disease
Cardiorenal’ s mission is to improve chronic patient care with our unique digital therapeutic solutions relying on blood biomarkers monitored at home
Around 700 million
People with chronic kidney disease in the world1, with likely many more still undiagnosed
Expenses
2- 3% of annual heathcare budget spent in end stage renal disease treatment2
Treatment
Up to 40-50% with CKD may be affected by hyperkalemia and have under-dosed life saving drugs treatment3,4
Cardiovascular
Associated events account four up to 30% of death in patients with CKD5
- Bikbov B et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2020; 395(10225):709–33
- Bello AK et al. Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Brussels, Belgium: International Society of Nephrology; 2017. Available from: URL: www.theisn.org/global-atlas.
- National Kidney Foundation. Facts About High Potassium in Patients with Kidney Disease [cited 16 Oct 2020]. Available from: URL: https://www.kidney.org/atoz/content/hyperkalemia/facts.
- Pecoits-Filho R et al. Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care. J Clin Hypertens (Greenwich). 2019;21(7):991-1001.
- Thompson S et al. Cause of Death in Patients with Reduced Kidney Function. J Am Soc Nephrol 2015; 26(10):2504–11.

TENOR ©
An integrated digital therapeutic solution based on blood potassium monitoring at home.
CRIS ©
A software suite developed for any entity (company, hospital, etc.) wishing to have a ready-made and versatile remote patient monitoring tool.

Product under development not approved for sales

SOPRANO ©
An Evidence-based digital therapeutic solution intended to improve the treatment of Heart Failure patients at home.
Microfluidics
Electrochemistry
Used to transform blood ions concentrations in electrical signals that can be analysed
Artificial Intelligence
Leverage gathered biomarkers data and patient history to sharpen medical care and refine clinical decisions.
Contact Us
Our team
A team of high-level scientists passionate about helping to improve the health of a large number of chronic patients around the world.

Maurice Berenger
Chief Executive Officer

Guilhem Henrion
Chief Technical Officer

Julie Papillon
Operations Director

Daphné Laporte
QRA Manager

Moez Karoui
Cloud Application Manager

David Lefebvre
Industrialization Manager

Fengjuan WANG
Innovation Manager

Gabriel Lemercier
R&D project leader

David Rabaud
Industrialisation project leader
Board of directors

Maurice Berenger
Chief Executive Officer

Faiez Zannad
Founder

Didier Miraton
Independent Member







Awards
headquarter
29 Rue des grandes arcades, 67000 Strasbourg, FRANCE
contact@cardio-renal.com